Home

WILLIAM L ROPER

CIK 1087960 · last filed 2021-03-02

WILLIAM L ROPER is a corporate insider who has filed 138 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for CI, was dated Mar 2, 2021. Across all open-market trades the lifetime net is −$13.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.4M across reported positions. 132 SEC filings were submitted jointly with DAVITA INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.42M

Companies

4

Total Filings

138

Lifetime Open-Market Net

-$13.49M

Filer Profile

Reported Address
21250 HAWTHORNE BLVD
SUITE 800
TORRANCE, CA 90503
Related Filers
DAVITA INC. — 132 joint filings, latest 2020-06-15
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CI Director 8,595 $282.52 $2.43M -$541.4K 12 2021-03-02
DVA Director 16,234 $183.99 $2.99M -$9.88M 110 2020-06-15
Express Scripts Holding Co. (ESRX) Delisted Director 0 — — -$3.07M 9 2018-12-21
MEDCO HEALTH SOLUTIONS INC (MHS) Delisted Director 0 — — $0 7 2012-04-03

Recent Filings

138 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-03-02 CI Grant (A) +226 $0 EDGAR
2020-12-02 CI Grant (A) +227 $0 EDGAR
2020-09-02 CI Grant (A) +267 $0 EDGAR
2020-06-15 DVA Grant (A) +273 $0 EDGAR
2020-06-10 DVA Mixed — -$31.0K EDGAR
2020-06-02 CI Grant (A) +240 $0 EDGAR
2020-05-19 DVA Grant (A) +599 $0 EDGAR
2020-05-07 CI Mixed — -$179.9K EDGAR
2020-03-17 DVA Grant (A) +625 $0 EDGAR
2020-03-03 CI Grant (A) +259 $0 EDGAR
Showing 1–10 of 138
Page 1 of 14
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.